Dasatinib + Blinatumomab Active for Ph-Positive ALL in Adults
THURSDAY, Oct. 22, 2020 (HealthDay News) — Chemotherapy-free induction and consolidation first-line treatment with dasatinib and blinatumomab is associated with a high incidence of molecular response and survival in adults...
Read More